Category EXPLORE

Ros Deegan stands on the brink of a major breakthrough. Clinical trials are set to begin on new medicines developed by her venture, OMass Therapeutics, that target an adrenal disorder, among other things. If the medicines work they will immeasurably…

Blackstone, the world’s largest private capital firm, is looking to list some of its biggest investments in a move which could reignite the IPO market. Speaking alongside a third-quarter trading update to Wall Street today, Jonathan Gray, president of the…